Ampakines capable of improving cognition by enhancing brain activity under normal circumstances may also have the potential to reduce the harmful or unwanted effects of sleep deprivation. (CX717 by Cortex Pharmaceuticals)
Super eugeroic 'armodafinil' (Nuvigil), by modafinil’s creator, Cephalon, is FDA-approved. Ampakine CX717 from Cortex is in clinical trials. Both drugs promise even longer periods of wakefulness.
Armodafinil (Nuvigil®) is an eugeroic drug made by Cephalon, FDA-approved 6/15/2007. Clinical trials for its use in bipolar disorder, cognition in schizophrenia, excessive fatigue in Parkinson's & cancer, begin. Patent expires 2023.
Armodafinil From Wikipedia, the free encyclopedia Jump to: navigation, search Armodafinil Systematic (IUPAC) name (-)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide Identifiers CAS number 68693-11-8 ATC code N06BA07 PubChem ? Chemical data Formu
Here's just one: Even talking about posthuman psychological superhealth is morally frivolous. Another? Promoting superhappiness may lead to what one may call, informally, "inappropriate" behavioural responses.
Full-text, online textbook discussing various pharmaceutical, neutraceutical, and lifestyle interventions for enhancing life by facilitating our efforts to reach our fullest potential.
Modafinil induces wakefulness, but its dopamine-releasing action in the nucleus accumbens is weak and dose-dependent; no likelihood of euphoric response ('abuse potential').
Even the lowest dose of modafinil, an ampakine, improved the wakefulness and cognitive performance of sleep-deprived people; they work in part by boosting glutamate, a key neurotransmitter that facilitates learning & learn and encodes memory.
Thanks to AIDS activists it has been legal for several years in the United States to order, for personal use, a 3 month supply of non-Schedule I or II drugs, from overseas. We view International Antiaging Systems (IAS) as a reliable source. We've shared b